Industry Research Reports

Part 1

Part 2

Part 3

Part 4

Part 5

Home > Reports > Medical Care > Single Cell Multiomics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Single Cell Multiomics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

Industry: Medical Care

Published: 2025-02-07

Pages: 134 Pages

Report ld: 3670406

Request Sample

Pre-Order Enquiry

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description

The global market for Single Cell Multiomics was estimated to be worth US$ 2036 million in 2024 and is forecast to a readjusted size of US$ 3575 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

Single Cell Multiomics Market Size(US$)

M= millions and B=billions

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

This report aims to provide a comprehensive presentation of the global market for Single Cell Multiomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Single Cell Multiomics by region & country, by Type, and by Application.

The Single Cell Multiomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Multiomics.

Market Segmentation

Report Metric
Details
Report Title
Single Cell Multiomics- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
Forecasted Market Size in 2031
US$ 3575 million
CAGR(2025-2031)
8.5%
Market Size Available for Years
2025-2031
Global Single Cell Multiomics Companies Covered
10x Genomics
Becton, Dickinson and Company
Berkeley Lights
BGI Genomics
Bio Rad Laboratories
Danaher Corporation (Cytiva Life Sciences)
Dolomite Bio
Epicypher
Fluidigm Corporation
Illimina
Miltenyi Biotec B.V. & CO.
Mission Bio
Nanostring Technologies
Olink Holding AB (Olink Proteomics)
Parse Bioscience
Qiagen N.V.
Takara Holdings Inc. Takara Bio Group
Thermo Fisher Scientific
Global Single Cell Multiomics Market, by Region
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Single Cell Multiomics Market, Segment by Type
by Type
by Technique
Global Single Cell Multiomics Market, Segment by Application
Oncology
Cell biology
Neurology
Immunology
Stem cell research
Forecast Units
Million USD
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Single Cell Multiomics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Single Cell Multiomics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Single Cell Multiomics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

1 Market Overview
    1.1 Single Cell Multiomics Product Introduction
    1.2 Global Single Cell Multiomics Market Size Forecast (2020-2031)
    1.3 Single Cell Multiomics Market Trends & Drivers
        1.3.1 Single Cell Multiomics Industry Trends
        1.3.2 Single Cell Multiomics Market Drivers & Opportunity
        1.3.3 Single Cell Multiomics Market Challenges
        1.3.4 Single Cell Multiomics Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

2 Competitive Analysis by Company
    2.1 Global Single Cell Multiomics Players Revenue Ranking (2024)
    2.2 Global Single Cell Multiomics Revenue by Company (2020-2025)
    2.3 Key Companies Single Cell Multiomics Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Single Cell Multiomics Product Offered
    2.5 Key Companies Time to Begin Mass Production of Single Cell Multiomics
    2.6 Single Cell Multiomics Market Competitive Analysis
        2.6.1 Single Cell Multiomics Market Concentration Rate (2020-2025)
        2.6.2 Global 5 and 10 Largest Companies by Single Cell Multiomics Revenue in 2024
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Multiomics as of 2024)
    2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 by Type
        3.1.2 by Technique
    3.2 Global Single Cell Multiomics Sales Value by Type
        3.2.1 Global Single Cell Multiomics Sales Value by Type (2020 VS 2024 VS 2031)
        3.2.2 Global Single Cell Multiomics Sales Value, by Type (2020-2031)
        3.2.3 Global Single Cell Multiomics Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Oncology
        4.1.2 Cell biology
        4.1.3 Neurology
        4.1.4 Immunology
        4.1.5 Stem cell research
    4.2 Global Single Cell Multiomics Sales Value by Application
        4.2.1 Global Single Cell Multiomics Sales Value by Application (2020 VS 2024 VS 2031)
        4.2.2 Global Single Cell Multiomics Sales Value, by Application (2020-2031)
        4.2.3 Global Single Cell Multiomics Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region
    5.1 Global Single Cell Multiomics Sales Value by Region
        5.1.1 Global Single Cell Multiomics Sales Value by Region: 2020 VS 2024 VS 2031
        5.1.2 Global Single Cell Multiomics Sales Value by Region (2020-2025)
        5.1.3 Global Single Cell Multiomics Sales Value by Region (2026-2031)
        5.1.4 Global Single Cell Multiomics Sales Value by Region (%), (2020-2031)
    5.2 North America
        5.2.1 North America Single Cell Multiomics Sales Value, 2020-2031
        5.2.2 North America Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031
    5.3 Europe
        5.3.1 Europe Single Cell Multiomics Sales Value, 2020-2031
        5.3.2 Europe Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031
    5.4 Asia Pacific
        5.4.1 Asia Pacific Single Cell Multiomics Sales Value, 2020-2031
        5.4.2 Asia Pacific Single Cell Multiomics Sales Value by Region (%), 2024 VS 2031
    5.5 South America
        5.5.1 South America Single Cell Multiomics Sales Value, 2020-2031
        5.5.2 South America Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Single Cell Multiomics Sales Value, 2020-2031
        5.6.2 Middle East & Africa Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Single Cell Multiomics Sales Value Growth Trends, 2020 VS 2024 VS 2031
    6.2 Key Countries/Regions Single Cell Multiomics Sales Value, 2020-2031
    6.3 United States
        6.3.1 United States Single Cell Multiomics Sales Value, 2020-2031
        6.3.2 United States Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
        6.3.3 United States Single Cell Multiomics Sales Value by Application, 2024 VS 2031
    6.4 Europe
        6.4.1 Europe Single Cell Multiomics Sales Value, 2020-2031
        6.4.2 Europe Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
        6.4.3 Europe Single Cell Multiomics Sales Value by Application, 2024 VS 2031
    6.5 China
        6.5.1 China Single Cell Multiomics Sales Value, 2020-2031
        6.5.2 China Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
        6.5.3 China Single Cell Multiomics Sales Value by Application, 2024 VS 2031
    6.6 Japan
        6.6.1 Japan Single Cell Multiomics Sales Value, 2020-2031
        6.6.2 Japan Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
        6.6.3 Japan Single Cell Multiomics Sales Value by Application, 2024 VS 2031
    6.7 South Korea
        6.7.1 South Korea Single Cell Multiomics Sales Value, 2020-2031
        6.7.2 South Korea Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
        6.7.3 South Korea Single Cell Multiomics Sales Value by Application, 2024 VS 2031
    6.8 Southeast Asia
        6.8.1 Southeast Asia Single Cell Multiomics Sales Value, 2020-2031
        6.8.2 Southeast Asia Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
        6.8.3 Southeast Asia Single Cell Multiomics Sales Value by Application, 2024 VS 2031
    6.9 India
        6.9.1 India Single Cell Multiomics Sales Value, 2020-2031
        6.9.2 India Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
        6.9.3 India Single Cell Multiomics Sales Value by Application, 2024 VS 2031

7 Company Profiles
    7.1 10x Genomics
        7.1.1 10x Genomics Profile
        7.1.2 10x Genomics Main Business
        7.1.3 10x Genomics Single Cell Multiomics Products, Services and Solutions
        7.1.4 10x Genomics Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.1.5 10x Genomics Recent Developments
    7.2 Becton, Dickinson and Company
        7.2.1 Becton, Dickinson and Company Profile
        7.2.2 Becton, Dickinson and Company Main Business
        7.2.3 Becton, Dickinson and Company Single Cell Multiomics Products, Services and Solutions
        7.2.4 Becton, Dickinson and Company Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.2.5 Becton, Dickinson and Company Recent Developments
    7.3 Berkeley Lights
        7.3.1 Berkeley Lights Profile
        7.3.2 Berkeley Lights Main Business
        7.3.3 Berkeley Lights Single Cell Multiomics Products, Services and Solutions
        7.3.4 Berkeley Lights Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.3.5 Berkeley Lights Recent Developments
    7.4 BGI Genomics
        7.4.1 BGI Genomics Profile
        7.4.2 BGI Genomics Main Business
        7.4.3 BGI Genomics Single Cell Multiomics Products, Services and Solutions
        7.4.4 BGI Genomics Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.4.5 BGI Genomics Recent Developments
    7.5 Bio Rad Laboratories
        7.5.1 Bio Rad Laboratories Profile
        7.5.2 Bio Rad Laboratories Main Business
        7.5.3 Bio Rad Laboratories Single Cell Multiomics Products, Services and Solutions
        7.5.4 Bio Rad Laboratories Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.5.5 Bio Rad Laboratories Recent Developments
    7.6 Danaher Corporation (Cytiva Life Sciences)
        7.6.1 Danaher Corporation (Cytiva Life Sciences) Profile
        7.6.2 Danaher Corporation (Cytiva Life Sciences) Main Business
        7.6.3 Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Products, Services and Solutions
        7.6.4 Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.6.5 Danaher Corporation (Cytiva Life Sciences) Recent Developments
    7.7 Dolomite Bio
        7.7.1 Dolomite Bio Profile
        7.7.2 Dolomite Bio Main Business
        7.7.3 Dolomite Bio Single Cell Multiomics Products, Services and Solutions
        7.7.4 Dolomite Bio Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.7.5 Dolomite Bio Recent Developments
    7.8 Epicypher
        7.8.1 Epicypher Profile
        7.8.2 Epicypher Main Business
        7.8.3 Epicypher Single Cell Multiomics Products, Services and Solutions
        7.8.4 Epicypher Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.8.5 Epicypher Recent Developments
    7.9 Fluidigm Corporation
        7.9.1 Fluidigm Corporation Profile
        7.9.2 Fluidigm Corporation Main Business
        7.9.3 Fluidigm Corporation Single Cell Multiomics Products, Services and Solutions
        7.9.4 Fluidigm Corporation Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.9.5 Fluidigm Corporation Recent Developments
    7.10 Illimina
        7.10.1 Illimina Profile
        7.10.2 Illimina Main Business
        7.10.3 Illimina Single Cell Multiomics Products, Services and Solutions
        7.10.4 Illimina Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.10.5 Illimina Recent Developments
    7.11 Miltenyi Biotec B.V. & CO.
        7.11.1 Miltenyi Biotec B.V. & CO. Profile
        7.11.2 Miltenyi Biotec B.V. & CO. Main Business
        7.11.3 Miltenyi Biotec B.V. & CO. Single Cell Multiomics Products, Services and Solutions
        7.11.4 Miltenyi Biotec B.V. & CO. Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.11.5 Miltenyi Biotec B.V. & CO. Recent Developments
    7.12 Mission Bio
        7.12.1 Mission Bio Profile
        7.12.2 Mission Bio Main Business
        7.12.3 Mission Bio Single Cell Multiomics Products, Services and Solutions
        7.12.4 Mission Bio Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.12.5 Mission Bio Recent Developments
    7.13 Nanostring Technologies
        7.13.1 Nanostring Technologies Profile
        7.13.2 Nanostring Technologies Main Business
        7.13.3 Nanostring Technologies Single Cell Multiomics Products, Services and Solutions
        7.13.4 Nanostring Technologies Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.13.5 Nanostring Technologies Recent Developments
    7.14 Olink Holding AB (Olink Proteomics)
        7.14.1 Olink Holding AB (Olink Proteomics) Profile
        7.14.2 Olink Holding AB (Olink Proteomics) Main Business
        7.14.3 Olink Holding AB (Olink Proteomics) Single Cell Multiomics Products, Services and Solutions
        7.14.4 Olink Holding AB (Olink Proteomics) Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.14.5 Olink Holding AB (Olink Proteomics) Recent Developments
    7.15 Parse Bioscience
        7.15.1 Parse Bioscience Profile
        7.15.2 Parse Bioscience Main Business
        7.15.3 Parse Bioscience Single Cell Multiomics Products, Services and Solutions
        7.15.4 Parse Bioscience Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.15.5 Parse Bioscience Recent Developments
    7.16 Qiagen N.V.
        7.16.1 Qiagen N.V. Profile
        7.16.2 Qiagen N.V. Main Business
        7.16.3 Qiagen N.V. Single Cell Multiomics Products, Services and Solutions
        7.16.4 Qiagen N.V. Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.16.5 Qiagen N.V. Recent Developments
    7.17 Takara Holdings Inc. Takara Bio Group
        7.17.1 Takara Holdings Inc. Takara Bio Group Profile
        7.17.2 Takara Holdings Inc. Takara Bio Group Main Business
        7.17.3 Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Products, Services and Solutions
        7.17.4 Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.17.5 Takara Holdings Inc. Takara Bio Group Recent Developments
    7.18 Thermo Fisher Scientific
        7.18.1 Thermo Fisher Scientific Profile
        7.18.2 Thermo Fisher Scientific Main Business
        7.18.3 Thermo Fisher Scientific Single Cell Multiomics Products, Services and Solutions
        7.18.4 Thermo Fisher Scientific Single Cell Multiomics Revenue (US$ Million) & (2020-2025)
        7.18.5 Thermo Fisher Scientific Recent Developments

8 Industry Chain Analysis
    8.1 Single Cell Multiomics Industrial Chain
    8.2 Single Cell Multiomics Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Single Cell Multiomics Sales Model
        8.5.2 Sales Channel
        8.5.3 Single Cell Multiomics Distributors

9 Research Findings and Conclusion

10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
            10.1.1.1 Research Programs/Design
            10.1.1.2 Market Size Estimation
            10.1.1.3 Market Breakdown and Data Triangulation
        10.1.2 Data Source
            10.1.2.1 Secondary Sources
            10.1.2.2 Primary Sources
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Single Cell Multiomics Market Trends
 Table 2. Single Cell Multiomics Market Drivers & Opportunity
 Table 3. Single Cell Multiomics Market Challenges
 Table 4. Single Cell Multiomics Market Restraints
 Table 5. Global Single Cell Multiomics Revenue by Company (2020-2025) & (US$ Million)
 Table 6. Global Single Cell Multiomics Revenue Market Share by Company (2020-2025)
 Table 7. Key Companies Single Cell Multiomics Manufacturing Base Distribution and Headquarters
 Table 8. Key Companies Single Cell Multiomics Product Type
 Table 9. Key Companies Time to Begin Mass Production of Single Cell Multiomics
 Table 10. Global Single Cell Multiomics Companies Market Concentration Ratio (CR5 and HHI)
 Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Single Cell Multiomics as of 2024)
 Table 12. Mergers & Acquisitions, Expansion Plans
 Table 13. Global Single Cell Multiomics Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)
 Table 14. Global Single Cell Multiomics Sales Value by Type (2020-2025) & (US$ Million)
 Table 15. Global Single Cell Multiomics Sales Value by Type (2026-2031) & (US$ Million)
 Table 16. Global Single Cell Multiomics Sales Market Share in Value by Type (2020-2025)
 Table 17. Global Single Cell Multiomics Sales Market Share in Value by Type (2026-2031)
 Table 18. Global Single Cell Multiomics Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)
 Table 19. Global Single Cell Multiomics Sales Value by Application (2020-2025) & (US$ Million)
 Table 20. Global Single Cell Multiomics Sales Value by Application (2026-2031) & (US$ Million)
 Table 21. Global Single Cell Multiomics Sales Market Share in Value by Application (2020-2025)
 Table 22. Global Single Cell Multiomics Sales Market Share in Value by Application (2026-2031)
 Table 23. Global Single Cell Multiomics Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)
 Table 24. Global Single Cell Multiomics Sales Value by Region (2020-2025) & (US$ Million)
 Table 25. Global Single Cell Multiomics Sales Value by Region (2026-2031) & (US$ Million)
 Table 26. Global Single Cell Multiomics Sales Value by Region (2020-2025) & (%)
 Table 27. Global Single Cell Multiomics Sales Value by Region (2026-2031) & (%)
 Table 28. Key Countries/Regions Single Cell Multiomics Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031
 Table 29. Key Countries/Regions Single Cell Multiomics Sales Value, (2020-2025) & (US$ Million)
 Table 30. Key Countries/Regions Single Cell Multiomics Sales Value, (2026-2031) & (US$ Million)
 Table 31. 10x Genomics Basic Information List
 Table 32. 10x Genomics Description and Business Overview
 Table 33. 10x Genomics Single Cell Multiomics Products, Services and Solutions
 Table 34. Revenue (US$ Million) in Single Cell Multiomics Business of 10x Genomics (2020-2025)
 Table 35. 10x Genomics Recent Developments
 Table 36. Becton, Dickinson and Company Basic Information List
 Table 37. Becton, Dickinson and Company Description and Business Overview
 Table 38. Becton, Dickinson and Company Single Cell Multiomics Products, Services and Solutions
 Table 39. Revenue (US$ Million) in Single Cell Multiomics Business of Becton, Dickinson and Company (2020-2025)
 Table 40. Becton, Dickinson and Company Recent Developments
 Table 41. Berkeley Lights Basic Information List
 Table 42. Berkeley Lights Description and Business Overview
 Table 43. Berkeley Lights Single Cell Multiomics Products, Services and Solutions
 Table 44. Revenue (US$ Million) in Single Cell Multiomics Business of Berkeley Lights (2020-2025)
 Table 45. Berkeley Lights Recent Developments
 Table 46. BGI Genomics Basic Information List
 Table 47. BGI Genomics Description and Business Overview
 Table 48. BGI Genomics Single Cell Multiomics Products, Services and Solutions
 Table 49. Revenue (US$ Million) in Single Cell Multiomics Business of BGI Genomics (2020-2025)
 Table 50. BGI Genomics Recent Developments
 Table 51. Bio Rad Laboratories Basic Information List
 Table 52. Bio Rad Laboratories Description and Business Overview
 Table 53. Bio Rad Laboratories Single Cell Multiomics Products, Services and Solutions
 Table 54. Revenue (US$ Million) in Single Cell Multiomics Business of Bio Rad Laboratories (2020-2025)
 Table 55. Bio Rad Laboratories Recent Developments
 Table 56. Danaher Corporation (Cytiva Life Sciences) Basic Information List
 Table 57. Danaher Corporation (Cytiva Life Sciences) Description and Business Overview
 Table 58. Danaher Corporation (Cytiva Life Sciences) Single Cell Multiomics Products, Services and Solutions
 Table 59. Revenue (US$ Million) in Single Cell Multiomics Business of Danaher Corporation (Cytiva Life Sciences) (2020-2025)
 Table 60. Danaher Corporation (Cytiva Life Sciences) Recent Developments
 Table 61. Dolomite Bio Basic Information List
 Table 62. Dolomite Bio Description and Business Overview
 Table 63. Dolomite Bio Single Cell Multiomics Products, Services and Solutions
 Table 64. Revenue (US$ Million) in Single Cell Multiomics Business of Dolomite Bio (2020-2025)
 Table 65. Dolomite Bio Recent Developments
 Table 66. Epicypher Basic Information List
 Table 67. Epicypher Description and Business Overview
 Table 68. Epicypher Single Cell Multiomics Products, Services and Solutions
 Table 69. Revenue (US$ Million) in Single Cell Multiomics Business of Epicypher (2020-2025)
 Table 70. Epicypher Recent Developments
 Table 71. Fluidigm Corporation Basic Information List
 Table 72. Fluidigm Corporation Description and Business Overview
 Table 73. Fluidigm Corporation Single Cell Multiomics Products, Services and Solutions
 Table 74. Revenue (US$ Million) in Single Cell Multiomics Business of Fluidigm Corporation (2020-2025)
 Table 75. Fluidigm Corporation Recent Developments
 Table 76. Illimina Basic Information List
 Table 77. Illimina Description and Business Overview
 Table 78. Illimina Single Cell Multiomics Products, Services and Solutions
 Table 79. Revenue (US$ Million) in Single Cell Multiomics Business of Illimina (2020-2025)
 Table 80. Illimina Recent Developments
 Table 81. Miltenyi Biotec B.V. & CO. Basic Information List
 Table 82. Miltenyi Biotec B.V. & CO. Description and Business Overview
 Table 83. Miltenyi Biotec B.V. & CO. Single Cell Multiomics Products, Services and Solutions
 Table 84. Revenue (US$ Million) in Single Cell Multiomics Business of Miltenyi Biotec B.V. & CO. (2020-2025)
 Table 85. Miltenyi Biotec B.V. & CO. Recent Developments
 Table 86. Mission Bio Basic Information List
 Table 87. Mission Bio Description and Business Overview
 Table 88. Mission Bio Single Cell Multiomics Products, Services and Solutions
 Table 89. Revenue (US$ Million) in Single Cell Multiomics Business of Mission Bio (2020-2025)
 Table 90. Mission Bio Recent Developments
 Table 91. Nanostring Technologies Basic Information List
 Table 92. Nanostring Technologies Description and Business Overview
 Table 93. Nanostring Technologies Single Cell Multiomics Products, Services and Solutions
 Table 94. Revenue (US$ Million) in Single Cell Multiomics Business of Nanostring Technologies (2020-2025)
 Table 95. Nanostring Technologies Recent Developments
 Table 96. Olink Holding AB (Olink Proteomics) Basic Information List
 Table 97. Olink Holding AB (Olink Proteomics) Description and Business Overview
 Table 98. Olink Holding AB (Olink Proteomics) Single Cell Multiomics Products, Services and Solutions
 Table 99. Revenue (US$ Million) in Single Cell Multiomics Business of Olink Holding AB (Olink Proteomics) (2020-2025)
 Table 100. Olink Holding AB (Olink Proteomics) Recent Developments
 Table 101. Parse Bioscience Basic Information List
 Table 102. Parse Bioscience Description and Business Overview
 Table 103. Parse Bioscience Single Cell Multiomics Products, Services and Solutions
 Table 104. Revenue (US$ Million) in Single Cell Multiomics Business of Parse Bioscience (2020-2025)
 Table 105. Parse Bioscience Recent Developments
 Table 106. Qiagen N.V. Basic Information List
 Table 107. Qiagen N.V. Description and Business Overview
 Table 108. Qiagen N.V. Single Cell Multiomics Products, Services and Solutions
 Table 109. Revenue (US$ Million) in Single Cell Multiomics Business of Qiagen N.V. (2020-2025)
 Table 110. Qiagen N.V. Recent Developments
 Table 111. Takara Holdings Inc. Takara Bio Group Basic Information List
 Table 112. Takara Holdings Inc. Takara Bio Group Description and Business Overview
 Table 113. Takara Holdings Inc. Takara Bio Group Single Cell Multiomics Products, Services and Solutions
 Table 114. Revenue (US$ Million) in Single Cell Multiomics Business of Takara Holdings Inc. Takara Bio Group (2020-2025)
 Table 115. Takara Holdings Inc. Takara Bio Group Recent Developments
 Table 116. Thermo Fisher Scientific Basic Information List
 Table 117. Thermo Fisher Scientific Description and Business Overview
 Table 118. Thermo Fisher Scientific Single Cell Multiomics Products, Services and Solutions
 Table 119. Revenue (US$ Million) in Single Cell Multiomics Business of Thermo Fisher Scientific (2020-2025)
 Table 120. Thermo Fisher Scientific Recent Developments
 Table 121. Key Raw Materials Lists
 Table 122. Raw Materials Key Suppliers Lists
 Table 123. Single Cell Multiomics Downstream Customers
 Table 124. Single Cell Multiomics Distributors List
 Table 125. Research Programs/Design for This Report
 Table 126. Key Data Information from Secondary Sources
 Table 127. Key Data Information from Primary Sources
 Table 128. Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Single Cell Multiomics Product Picture
 Figure 2. Global Single Cell Multiomics Sales Value, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Global Single Cell Multiomics Sales Value (2020-2031) & (US$ Million)
 Figure 4. Single Cell Multiomics Report Years Considered
 Figure 5. Global Single Cell Multiomics Players Revenue Ranking (2024) & (US$ Million)
 Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Single Cell Multiomics Revenue in 2024
 Figure 7. Single Cell Multiomics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 8. by Type Picture
 Figure 9. by Technique Picture
 Figure 10. Global Single Cell Multiomics Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 11. Global Single Cell Multiomics Sales Value Market Share by Type, 2024 & 2031
 Figure 12. Product Picture of Oncology
 Figure 13. Product Picture of Cell biology
 Figure 14. Product Picture of Neurology
 Figure 15. Product Picture of Immunology
 Figure 16. Product Picture of Stem cell research
 Figure 17. Global Single Cell Multiomics Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)
 Figure 18. Global Single Cell Multiomics Sales Value Market Share by Application, 2024 & 2031
 Figure 19. North America Single Cell Multiomics Sales Value (2020-2031) & (US$ Million)
 Figure 20. North America Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031
 Figure 21. Europe Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 22. Europe Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031
 Figure 23. Asia Pacific Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 24. Asia Pacific Single Cell Multiomics Sales Value by Region (%), 2024 VS 2031
 Figure 25. South America Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 26. South America Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031
 Figure 27. Middle East & Africa Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 28. Middle East & Africa Single Cell Multiomics Sales Value by Country (%), 2024 VS 2031
 Figure 29. Key Countries/Regions Single Cell Multiomics Sales Value (%), (2020-2031)
 Figure 30. United States Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 31. United States Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
 Figure 32. United States Single Cell Multiomics Sales Value by Application (%), 2024 VS 2031
 Figure 33. Europe Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 34. Europe Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
 Figure 35. Europe Single Cell Multiomics Sales Value by Application (%), 2024 VS 2031
 Figure 36. China Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 37. China Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
 Figure 38. China Single Cell Multiomics Sales Value by Application (%), 2024 VS 2031
 Figure 39. Japan Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 40. Japan Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
 Figure 41. Japan Single Cell Multiomics Sales Value by Application (%), 2024 VS 2031
 Figure 42. South Korea Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 43. South Korea Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
 Figure 44. South Korea Single Cell Multiomics Sales Value by Application (%), 2024 VS 2031
 Figure 45. Southeast Asia Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 46. Southeast Asia Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
 Figure 47. Southeast Asia Single Cell Multiomics Sales Value by Application (%), 2024 VS 2031
 Figure 48. India Single Cell Multiomics Sales Value, (2020-2031) & (US$ Million)
 Figure 49. India Single Cell Multiomics Sales Value by Type (%), 2024 VS 2031
 Figure 50. India Single Cell Multiomics Sales Value by Application (%), 2024 VS 2031
 Figure 51. Single Cell Multiomics Industrial Chain
 Figure 52. Single Cell Multiomics Manufacturing Cost Structure
 Figure 53. Channels of Distribution (Direct Sales, and Distribution)
 Figure 54. Bottom-up and Top-down Approaches for This Report
 Figure 55. Data Triangulation
 Figure 56. Key Executives Interviewed

Description

The global market for Single Cell Multiomics was estimated to be worth US$ 2036 million in 2024 and is forecast to a readjusted size of US$ 3575 million by 2031 with a CAGR of 8.5% during the forecast period 2025-2031.

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.

This report aims to provide a comprehensive presentation of the global market for Single Cell Multiomics, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Single Cell Multiomics by region & country, by Type, and by Application.

The Single Cell Multiomics market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Single Cell Multiomics.

Market Segmentation

Related Reports

Single Cell Multiomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
Published: 2024-01-11
Pages: 138
USD 3950.00
(Single User License)
Global Single Cell Multiomics Market Research Report 2024
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
Published: 2024-01-20
Pages: 97
USD 2900.00
(Single User License)
Global Single Cell Multiomics Market Research Report 2025
The global market for Single Cell Multiomics was valued at US$ 2036 million in the year 2024 and is projected to reach a revised size of US$ 3575 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published: 2025-02-07
Pages: 100
USD 2900.00
(Single User License)

Single Cell Multiomics - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
Published: 2024-01-11
Pages: 138
USD 3950.00 ()
Global Single Cell Multiomics Market Research Report 2024
Single cell multiomics technologies typically measure multiple types of molecules from the same individual cell, allowing for more in-depth biological insight than can be gained by analyzing each molecular layer from separate cells. Single-cell multimodal omics (scMulti-omics) technologies allow for the measurement of multiple modalities from the same cell, including DNA methylation, chromatin accessibility, RNA expression, protein abundance, gene perturbation, and spatial information, unlike live-cell fluorescence imaging, which involves the destruction of cells for analysis.
Published: 2024-01-20
Pages: 97
USD 2900.00 ()
Global Single Cell Multiomics Market Research Report 2025
The global market for Single Cell Multiomics was valued at US$ 2036 million in the year 2024 and is projected to reach a revised size of US$ 3575 million by 2031, growing at a CAGR of 8.5% during the forecast period.
Published: 2025-02-07
Pages: 100
USD 2900.00 ()